Cargando…

Effectiveness of Physical Activity Interventions on Cognition, Neuropsychiatric Symptoms, and Quality of Life of Alzheimer’s Disease: An Update of a Systematic Review and Meta-Analysis

The topic of physical activity interventions for the treatment of Alzheimer’s disease (AD) has been discussed for decades, but there are still inconsistent views on the effect of its intervention in different studies. With the increase in randomized controlled trials (RCTs), it is necessary to updat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Ya-Jing, Su, Qing-Wen, Sheng, Zhi-Ren, Weng, Qiu-Yan, Niu, Yan-Fang, Zhou, Hong-Di, Liu, Chun-Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926300/ https://www.ncbi.nlm.nih.gov/pubmed/35309887 http://dx.doi.org/10.3389/fnagi.2022.830824

Ejemplares similares

Neuropsychiatric Symptoms Mediated the Relationship Between Odor Identification and Cognition in Alzheimer's Disease Spectrum: A Structural Equation Model Analysis
por: Wang, Qiang, et al.
Publicado: (2022)

The cognitive dysfunction of claustrum on Alzheimer’s disease: A mini-review
por: Chen, Chun-Yan, et al.
Publicado: (2023)

Potential roles of oxidative distress on neurodegeneration in Parkinson's disease with neuropsychiatric symptoms
por: Li, Dan-ning, et al.
Publicado: (2022)

Associations Between Oral Health Status, Perceived Stress, and Neuropsychiatric Symptoms Among Community Individuals With Alzheimer's Disease: A Mediation Analysis
por: Yang, Bing, et al.
Publicado: (2022)

The Neuropsychiatric Changes After COVID-19 Quarantine in Patients With Cognitive Impairment and Their Caregivers in Chongqing, China: A Cohort Study
por: Yuan, Shiyun, et al.
Publicado: (2022)

Alzheimer’s Disease: An Update and Insights Into Pathophysiology
por: Abubakar, Murtala Bello, et al.
Publicado: (2022)

Optimized Magnetic Stimulation Induced Hypoconnectivity Within the Executive Control Network Yields Cognition Improvements in Alzheimer’s Patients
por: Xiao, Guixian, et al.
Publicado: (2022)

The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions
por: Hunsberger, Holly C., et al.
Publicado: (2019)

Constructing a prognostic risk model for Alzheimer’s disease based on ferroptosis
por: Wang, Xiao-Li, et al.
Publicado: (2023)

A Conceptual View of Cognitive Intervention in Older Adults With and Without Cognitive Decline—A Systemic Review
por: Mendes, Liliana, et al.
Publicado: (2022)

Identifying Alzheimer’s disease and mild cognitive impairment with atlas-based multi-modal metrics
por: Long, Zhuqing, et al.
Publicado: (2023)

Research progress on vestibular dysfunction and visual–spatial cognition in patients with Alzheimer’s disease
por: Huang, Yan, et al.
Publicado: (2023)

Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies
por: Keszycki, Rachel, et al.
Publicado: (2023)

Effects of Cognitive Reserve in Alzheimer’s Disease and Cognitively Unimpaired Individuals
por: Lee, Dong Hyuk, et al.
Publicado: (2022)

An update on the use of gamma (multi)sensory stimulation for Alzheimer’s disease treatment
por: Manippa, Valerio, et al.
Publicado: (2022)

Editorial: Alzheimer-related affective symptoms – mechanism and treatment
por: Nitzan, Keren, et al.
Publicado: (2023)

Changes in Serum Cystatin C Levels and the Associations With Cognitive Function in Alzheimer's Disease Patients
por: Chen, Xueping, et al.
Publicado: (2022)

Association between cerebrospinal fluid clusterin and biomarkers of Alzheimer’s disease pathology in mild cognitive impairment: a longitudinal cohort study
por: Wang, Hao, et al.
Publicado: (2023)

Postoperative Cognitive Dysfunction and Alzheimer’s Disease: A Transcriptome-Based Comparison of Animal Models
por: Wang, Yi-Wei, et al.
Publicado: (2022)

An update on mobile applications collecting data among subjects with or at risk of Alzheimer's disease
por: Piendel, Lydia, et al.
Publicado: (2023)

Plasma tau proteins for the diagnosis of mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis
por: Chen, Leian, et al.
Publicado: (2022)

Effect of exercise on cognitive function and synaptic plasticity in Alzheimer's disease models: A systematic review and meta-analysis
por: Guo, Linlin, et al.
Publicado: (2023)

Simufilam suppresses overactive mTOR and restores its sensitivity to insulin in Alzheimer’s disease patient lymphocytes
por: Wang, Hoau-Yan, et al.
Publicado: (2023)

Effects of the multidomain intervention with nutritional supplements on cognition and gut microbiome in early symptomatic Alzheimer’s disease: a randomized controlled trial
por: Lee, Eun Hye, et al.
Publicado: (2023)

Editorial: Neuroimaging Biomarkers and Cognition in Alzheimer's Disease Spectrum
por: Chen, Jiu, et al.
Publicado: (2022)

Weight Change and Neuropsychiatric Symptoms in Alzheimer’s Disease and Frontotemporal Dementia: Associations with Cognitive Decline
por: Morrow, Christopher B., et al.
Publicado: (2023)

Preoperative red cell distribution width predicts postoperative cognitive dysfunction after coronary artery bypass grafting
por: Wan, Jing, et al.
Publicado: (2020)

Loop diuretics association with Alzheimer’s disease risk
por: Graber-Naidich, Anna, et al.
Publicado: (2023)

Feasibility of a pilot dyadic randomized controlled trial testing the effects of three behavioral interventions on older adults’ cognitive, physical and everyday function
por: Phillips, Christine B., et al.
Publicado: (2023)

Cerebrospinal fluid neurofilament dynamic profiles predict cognitive progression in individuals with de novo Parkinson’s disease
por: Sheng, Ze-Hu, et al.
Publicado: (2022)

Retinal Microvascular Changes in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review, Meta-Analysis, and Meta-Regression
por: Yeh, Tsai-Chu, et al.
Publicado: (2022)

G-quadruplexes and associated proteins in aging and Alzheimer’s disease
por: Vijay Kumar, M. J., et al.
Publicado: (2023)

Neuropsychiatric symptoms in cognitively normal older persons, and the association with Alzheimer’s and non-Alzheimer’s dementia
por: Liew, Tau Ming
Publicado: (2020)

Practice effects in cognitive assessments three years later in non-carriers but not in symptom-free mutation carriers of autosomal-dominant Alzheimer's disease: Exemplifying procedural learning and memory?
por: Almkvist, Ove, et al.
Publicado: (2022)

Tau as a biomarker of cognitive impairment and neuropsychiatric symptom in Alzheimer's disease
por: Dang, Mingxi, et al.
Publicado: (2022)

Blood levels of circulating methionine components in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis
por: Zhao, Yan, et al.
Publicado: (2022)

Olfactory function changes and the predictive performance of the Chinese Smell Identification Test in patients with mild cognitive impairment and Alzheimer's disease
por: Mi, Yan, et al.
Publicado: (2023)

Decreased Netrin-1 in Mild Cognitive Impairment and Alzheimer’s Disease Patients
por: Ju, Ting, et al.
Publicado: (2022)

Association of inflammatory bowel disease and related medication exposure with risk of Alzheimer's disease: An updated meta-analysis
por: Xing, Yinghao, et al.
Publicado: (2023)

Editorial: Molecular mechanisms of Alzheimer’s disease: From top to bottom
por: Mello-Carpes, Pâmela B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_75odpnpjupjuq604jtb4fdvm9l